Literature DB >> 21320567

Regulation of MMP-9 expression by the A2b adenosine receptor and its dependency on TNF-α signaling.

Hongjie Chen1, Milka Koupenova, Dan Yang, Siddika Selva Sume, Philip C Trackman, Katya Ravid.   

Abstract

OBJECTIVE: Macrophage- and vascular-derived matrix metalloproteinase (MMP)-9 plays an important role in neointima formation after vascular injury. The A2b adenosine receptor (A2bAR) elevates cyclic adenosine monophosphate and suppresses tumor necrosis factor-α (TNF-α) levels at baseline and after vascular injury. Considering the influences of TNF-α on MMP-9 expression and activity, here we examined the effect of the A2bAR on the expression of MMP-9 and its potential dependency on TNF-α.
MATERIALS AND METHODS: We applied protein activity and mRNA analyses of MMP-9 in macrophages derived from A2bAR knockout (KO) and TNF-α receptor KO mice. We employed guidewire-induced femoral artery injuries on A2bAR KO and control mice and analyzed by immunohistochemistry MMP-9 expression in the neointima area.
RESULTS: MMP-9 activity is somewhat less in resident A2bAR KO macrophages compared with wild-type cells. However, MMP-9 is increased in activated macrophages from A2bAR KO when TNF-α is further elevated, or in wild-type cells after TNF-α treatment. In accordance, A2bAR activation downregulates MMP-9 expression in wild-type macrophages, which is ablated in TNF-α receptor KO cells. A greater vascular lesion after femoral artery injury in A2bAR KO mice is associated with elevated TNF-α levels and augmented MMP-9, compared to control mice.
CONCLUSIONS: Ablation of the A2bAR in activated macrophages increases MMP-9. A2bAR activation reduces MMP-9 expression, which depends on TNF-α and could contribute to the protective role of A2bAR in a vascular injury model.
Copyright © 2011 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21320567      PMCID: PMC5983365          DOI: 10.1016/j.exphem.2011.02.004

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  28 in total

Review 1.  Ena/VASP proteins: regulators of the actin cytoskeleton and cell migration.

Authors:  Matthias Krause; Erik W Dent; James E Bear; Joseph J Loureiro; Frank B Gertler
Journal:  Annu Rev Cell Dev Biol       Date:  2003       Impact factor: 13.827

2.  Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice.

Authors:  Peter J Gough; Ivan G Gomez; Paul T Wille; Elaine W Raines
Journal:  J Clin Invest       Date:  2005-12-22       Impact factor: 14.808

Review 3.  A(2B) adenosine receptors in immunity and inflammation.

Authors:  György Haskó; Balázs Csóka; Zoltán H Németh; E Sylvester Vizi; Pál Pacher
Journal:  Trends Immunol       Date:  2009-05-07       Impact factor: 16.687

4.  TNFalpha-induced MMP-9 promotes macrophage recruitment into injured peripheral nerve.

Authors:  Veronica I Shubayev; Mila Angert; Jennifer Dolkas; W Marie Campana; Kai Palenscar; Robert R Myers
Journal:  Mol Cell Neurosci       Date:  2005-11-16       Impact factor: 4.314

5.  Adenosine inhibits matrix metalloproteinase-9 secretion by neutrophils: implication of A2a receptor and cAMP/PKA/Ca2+ pathway.

Authors:  Isabelle Ernens; Didier Rouy; Emilie Velot; Yvan Devaux; Daniel R Wagner
Journal:  Circ Res       Date:  2006-08-17       Impact factor: 17.367

Review 6.  Adenosine receptors as promising therapeutic targets for drug development in chronic airway inflammation.

Authors:  Riccardo Polosa; Stephen T Holgate
Journal:  Curr Drug Targets       Date:  2006-06       Impact factor: 3.465

7.  TNF-alpha up-regulates matrix metalloproteinase-9 expression and activity in alveolar macrophages from patients with chronic obstructive pulmonary disease.

Authors:  Yaqing Li; Zhenxiang Zhang; Yongjian Xu; Shengdao Xiong; Wang Ni; Shixin Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

8.  B-Myb regulates the A(2B) adenosine receptor in vascular smooth muscle cells.

Authors:  Cynthia St Hilaire; Dan Yang; Barbara M Schreiber; Katya Ravid
Journal:  J Cell Biochem       Date:  2008-04-15       Impact factor: 4.429

9.  TNF-alpha upregulates the A2B adenosine receptor gene: The role of NAD(P)H oxidase 4.

Authors:  Cynthia St Hilaire; Milka Koupenova; Shannon H Carroll; Barbara D Smith; Katya Ravid
Journal:  Biochem Biophys Res Commun       Date:  2008-07-21       Impact factor: 3.575

10.  The A2b adenosine receptor protects against vascular injury.

Authors:  Dan Yang; Milka Koupenova; Donald J McCrann; Katherine J Kopeikina; Herbert M Kagan; Barbara M Schreiber; Katya Ravid
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-09       Impact factor: 11.205

View more
  9 in total

1.  Inhibition of tPA-induced hemorrhagic transformation involves adenosine A2b receptor activation after cerebral ischemia.

Authors:  Qiang Li; Xiaoning Han; Xi Lan; Xiaohua Hong; Qian Li; Yufeng Gao; Tianqi Luo; Qingwu Yang; Raymond C Koehler; Yu Zhai; Jinyuan Zhou; Jian Wang
Journal:  Neurobiol Dis       Date:  2017-08-19       Impact factor: 5.996

2.  Enhanced migration of breast and lung cancer cells deficient for cN-II and CD73 via COX-2/PGE2/AKT axis regulation.

Authors:  Octavia Cadassou; Muhammad-Zawwad Raza; Christelle Machon; Laura Gudefin; Célia Armanet; Kamel Chettab; Jérôme Guitton; Maria Grazia Tozzi; Charles Dumontet; Emeline Cros-Perrial; Lars Petter Jordheim
Journal:  Cell Oncol (Dordr)       Date:  2020-09-24       Impact factor: 6.730

3.  A2A adenosine receptor modulates drug efflux transporter P-glycoprotein at the blood-brain barrier.

Authors:  Do-Geun Kim; Margaret S Bynoe
Journal:  J Clin Invest       Date:  2016-04-04       Impact factor: 14.808

Review 4.  Regulation of atherosclerosis and associated risk factors by adenosine and adenosine receptors.

Authors:  Milka Koupenova; Hillary Johnston-Cox; Katya Ravid
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

5.  HIF-1α regulates A2B adenosine receptor expression in liver cancer cells.

Authors:  Jae Hyun Kwon; Jooyoung Lee; Jiye Kim; Yong Hwa Jo; Varvara A Kirchner; Nayoung Kim; Bong Jun Kwak; Shin Hwang; Gi-Won Song; Sung-Gyu Lee; Young-In Yoon; Gil-Chun Park; Eunyoung Tak
Journal:  Exp Ther Med       Date:  2019-10-07       Impact factor: 2.447

6.  Protective Effect of Adenosine A2B Receptor Agonist, BAY60-6583, Against Transient Focal Brain Ischemia in Rat.

Authors:  Ilaria Dettori; Lisa Gaviano; Filippo Ugolini; Daniele Lana; Irene Bulli; Giada Magni; Francesca Rossi; Maria Grazia Giovannini; Felicita Pedata
Journal:  Front Pharmacol       Date:  2021-02-11       Impact factor: 5.810

7.  TIM-4 in macrophages contributes to nasal polyp formation through the TGF-β1-mediated epithelial to mesenchymal transition in nasal epithelial cells.

Authors:  Danxue Qin; Peiqiang Liu; Huiqin Zhou; Jing Jin; Wanyang Gong; Kunyu Liu; Siyuan Chen; Jingyu Huang; Wenjun Fan; Zezhang Tao; Yu Xu
Journal:  Front Immunol       Date:  2022-08-05       Impact factor: 8.786

8.  A2A adenosine receptor agonist reduced MMP8 expression in healthy M2-like macrophages but not in macrophages from ankylosing spondylitis patients.

Authors:  Omid Sadatpour; Mohammad Taha Ebrahimi; Maryam Akhtari; Nooshin Ahmadzadeh; Mahdi Vojdanian; Ahmadreza Jamshidi; Elham Farhadi; Mahdi Mahmoudi
Journal:  BMC Musculoskelet Disord       Date:  2022-10-12       Impact factor: 2.562

Review 9.  Metabolite G-Protein Coupled Receptors in Cardio-Metabolic Diseases.

Authors:  Derek Strassheim; Timothy Sullivan; David C Irwin; Evgenia Gerasimovskaya; Tim Lahm; Dwight J Klemm; Edward C Dempsey; Kurt R Stenmark; Vijaya Karoor
Journal:  Cells       Date:  2021-11-29       Impact factor: 7.666

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.